A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand

• Status: Completed
• Trial end date: 2008-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine the safety and toleration of PEP005 Topical Gel, administered on an actinic keratosis (AK) treatment area on the top of a hand.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Peplin
• Collaborator: Omnicare Clinical Research

Criteria

Inclusion Criteria:

• Male patients at least 18 years of age.

• Post-menopausal female patients

• 4 to 8 clinically typical, visible and discrete AK lesions within an area on the dorsum of one hand.

• Written informed consent has been obtained.

• Agreement from the patient to allow photographs of the selected AK treatment area to be taken and used as part of the study data package.